Medication info

Hartmann's Solution

Prescription medicationIntravenous injection
Ingredient · strength
Sodium Lactate Solution›6.2g / 1000mLCalcium Chloride Hydrate›0.2g / 1000mLPotassium Chloride›0.3g / 1000mLSodium Chloride›6g / 1000mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
This medication is a colorless, transparent liquid with a slight salty taste, contained in clear glass or polypropylene containers, or multilayer film plastic materials.
Packaging
500mL/bottle, 1000mL/bottle, 500mL/bag, 1000mL/bag
Approval status
Active

MFDS item code 197000026 · Notified 1970.04.22 · Insurance code 645102662,645102672

Summary

Main use
Replacement and correction of extracellular fluid; improvement of metabolic acidosis
Who receives it
Adults
Adult administration
The usual dose for adults is 500~1,000mL per dose by intravenous drip infusion. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Replacement and correction of extracellular fluid; improvement of metabolic acidosis

View approved original text

This medication is used to replenish extracellular fluid and restore balance when circulating blood volume and interstitial fluid decrease. Additionally, it aids in correcting metabolic acidosis and improving the body's acid-base balance. Thus, it is employed to stabilize the body's fluid and electrolyte status and effectively manage metabolic abnormalities.

How it is given

Adult administration

The usual dose for adults is 500~1,000mL per dose by intravenous drip infusion. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Precautions

Do not administer this medication simultaneously with calcium-containing intravenous preparations and the specific antibiotic ceftriaxone, as precipitation may occur when using the same infusion device. An allergic reaction may occur while using this medication; therefore, if any hypersensitivity symptoms appear, administration should be stopped immediately and appropriate treatment sought. As this solution contains potassium, care must be taken in patients at high risk of hyperkalemia, such as those with impaired kidney function or heart disease, and blood potassium levels should be checked regularly. Due to the potential increase in sodium and chloride levels, it should be used cautiously in patients at risk of hypernatremia or hyperchloremia, especially in those with heart failure or liver disease, and electrolyte and kidney function should be monitored. This medication may cause hyponatremia; therefore, in patients at risk of hyponatremia, especially children, the elderly, and post-surgery patients, careful observation of blood sodium levels and neurological status is required. Due to the potential increase in calcium levels, it should be avoided in patients with hypercalcemia or a history of calcium kidney stones. Fluid overload may occur, so it should be administered carefully to patients with difficulty regulating fluid; continuous monitoring of fluid balance and electrolyte status is necessary for long-term administration. This medication should not be administered to patients with lactic acidosis, fluid overload, hypernatremia, or neonates, nor to those with hypersensitivity to this medication or its components. Use this medication cautiously in patients with severe renal or liver dysfunction, or heart failure, and adjust the rate of administration to be slow. Administration in large volumes or rapidly may result in side effects such as cerebral edema, pulmonary edema, and peripheral edema. When used with other medications, be cautious of interactions, especially when co-administered with drugs that increase the risk of hyperkalemia, hyponatremia, or hypercalcemia, frequent checks of blood electrolyte levels are required. During pregnancy, consider the risks to the fetus and administer only when necessary; for children and the elderly, adjust the rate of administration and closely monitor blood electrolyte status. Before administration, disinfect the patient's skin and equipment to prevent infection, warm the solution to body temperature, administer promptly after opening, and do not use any remaining solution.

Side effects

  • anaphylaxis
  • hypersensitivity
  • cerebral edema
  • pulmonary edema
  • peripheral edema
  • dyspnea
  • generalized urticarial
  • erythema
  • rash
  • hives
Show 14 more
  • vomiting
  • hypertension
  • tachycardia
  • chills
  • fever
  • hyperkalemia
  • hyponatremia
  • hypernatremia
  • hyperchloremic acidosis
  • electrolyte imbalance
  • fluid overload
  • hyponatremic encephalopathy
  • cardiac arrest
  • injection site pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help ensure the effectiveness of the medication.

Appearance and packaging

Appearance

This medication is a colorless, transparent liquid with a slight salty taste, contained in clear glass or polypropylene containers, or multilayer film plastic materials.

Package unit

500mL/bottle, 1000mL/bottle, 500mL/bag, 1000mL/bag

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.